Last update 17 Nov 2025

JKN2301

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
JKN2301
Target
Endonuclease
Action
inhibitors
Mechanism
Endonuclease inhibitors
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication
Influenza A virus infectionInfluenza B virus infection
Inactive Indication-
Originator Organization
Joincare Pharmaceutical Group Industry Co., Ltd.Joincare Pharmaceutical Group Industry Co., Ltd.
Active Organization
Joincare Pharmaceutical Group Industry Co., Ltd.Joincare Pharmaceutical Group Industry Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with JKN2301
CTR20254260
/ RecruitingPhase 3
评价JKN2301干混悬剂在2至12周岁以下流感儿童患者中安全性、药代动力学和有效性的多中心、随机、双盲双模拟、阳性对照药 III 期临床研究
[Translation] A multicenter, randomized, double-blind, double-dummy, active-controlled Phase III clinical study to evaluate the safety, pharmacokinetics, and efficacy of JKN2301 dry suspension in children aged 2 to 12 years with influenza.
CTR20252439
/ CompletedPhase 1
JKN2301干混悬剂与TG-1000胶囊在中国成年男性健康参与者空腹状态下单中心、随机、开放、单次给药、两序列、两周期、交叉设计的药代动力学比较研究
[Translation] A single-center, randomized, open-label, single-dose, two-sequence, two-period, crossover-design pharmacokinetic comparison study of JKN2301 dry suspension and TG-1000 capsules in healthy Chinese adult male participants under fasting state
100 Clinical Results associated with JKN2301
Login to view more data
100 Translational Medicine associated with JKN2301
Login to view more data
100 Patents (Medical) associated with JKN2301
Login to view more data
100 Deals associated with JKN2301
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Influenza A virus infectionPhase 3
China
Joincare Pharmaceutical Group Industry Co., Ltd.Joincare Pharmaceutical Group Industry Co., Ltd.
07 Nov 2025
Influenza B virus infectionPhase 3
China
Joincare Pharmaceutical Group Industry Co., Ltd.Joincare Pharmaceutical Group Industry Co., Ltd.
07 Nov 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free